Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0000899243-20-024078

Chief Business Officer sold 10,000 shares at an average $28.73 ($287,334)

  • Chief Business Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HENDERSON MICHAEL THOMAS · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-01 Exercise or conversion : show line 1 in the form +10,000 $0.16 $1,600 277,751 D
2020-09-01 Sale : show line 2 in the form −5,022 $27.89 $140,083 272,729 D
2020-09-01 Sale : show line 3 in the form −4,978 $29.58 $147,252 267,751 D
Open-market sales · 10,000 sh · avg $28.73 · $287,334

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-01 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −10,000 $0.16 2028-08-26 10,000 9,487 D
Loading xslF345X03/doc4.xml…